These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 19321268

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR, Bukstein OG, Douaihy AB, Clark DB, Chung TA, Daley DC, Wood DS, Brown SJ.
    Drug Alcohol Depend; 2010 Nov 01; 112(1-2):39-45. PubMed ID: 20576364
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, Koutsogiannis J, Phelan M, Mullen E, Harrison BJ, Rice S, Parker AG, Dean OM, Weller A, Kerr M, Quinn AL, Catania L, Kazantzis N, McGorry PD, Berk M.
    Lancet Psychiatry; 2019 Sep 01; 6(9):735-744. PubMed ID: 31371212
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER.
    Cornelius JR, Salloum IM, Ferrell R, Douaihy AB, Hayes J, Kirisci L, Horner M, Daley DC.
    Int J Med Biol Front; 2012 Sep 01; 18(6):399-411. PubMed ID: 25328373
    [Abstract] [Full Text] [Related]

  • 10. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R.
    Health Technol Assess; 2008 May 01; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [Abstract] [Full Text] [Related]

  • 11. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study.
    Cornelius JR, Clark DB, Bukstein OG, Kelly TM, Salloum IM, Wood DS.
    Addict Behav; 2005 May 01; 30(4):807-14. PubMed ID: 15833583
    [Abstract] [Full Text] [Related]

  • 12. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.
    Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK.
    Arch Pediatr Adolesc Med; 2007 Nov 01; 161(11):1026-34. PubMed ID: 17984403
    [Abstract] [Full Text] [Related]

  • 13. Analysis of Patient-reported Outcomes of Quality of Life and Functioning Before and After Treatment of Major Depressive Disorder Comorbid With Alcohol Use Disorders.
    Danovitch I, Steiner AJ, Kazdan A, Goldenberg M, Haglund M, Mirocha J, Collison K, Vanle B, Dang J, IsHak WW.
    J Addict Med; 2017 Nov 01; 11(1):47-54. PubMed ID: 27763941
    [Abstract] [Full Text] [Related]

  • 14. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation.
    Cornelius JR, Bukstein OG, Salloum IM, Kelly TM, Wood DS, Clark DB.
    J Child Adolesc Psychopharmacol; 2004 Nov 01; 14(1):33-8. PubMed ID: 15142389
    [Abstract] [Full Text] [Related]

  • 15. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L, Corcos M, Jeammet P.
    Encephale; 2005 Nov 01; 31(3):309-16. PubMed ID: 16142045
    [Abstract] [Full Text] [Related]

  • 16. A Randomized, Double-Blind, Placebo-Controlled Trial of Vilazodone in Children and Adolescents with Major Depressive Disorder with Twenty-Six-Week Open-Label Follow-Up.
    Findling RL, McCusker E, Strawn JR.
    J Child Adolesc Psychopharmacol; 2020 Jul 01; 30(6):355-365. PubMed ID: 32460523
    [Abstract] [Full Text] [Related]

  • 17. Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study.
    Pathak S, Kratochvil CJ, Rogers GM, Silva S, Vitiello B, Weller EB, March JS.
    Curr Psychiatry Rep; 2005 Dec 01; 7(6):429-34. PubMed ID: 16318820
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression.
    Krystal A, Fava M, Rubens R, Wessel T, Caron J, Wilson P, Roth T, McCall WV.
    J Clin Sleep Med; 2007 Feb 15; 3(1):48-55. PubMed ID: 17557453
    [Abstract] [Full Text] [Related]

  • 19. A double-blind efficacy and safety study of duloxetine fixed doses in children and adolescents with major depressive disorder.
    Emslie GJ, Prakash A, Zhang Q, Pangallo BA, Bangs ME, March JS.
    J Child Adolesc Psychopharmacol; 2014 May 15; 24(4):170-9. PubMed ID: 24815533
    [Abstract] [Full Text] [Related]

  • 20. Clinical messages from the Treatment for Adolescents With Depression Study (TADS).
    March JS, Vitiello B.
    Am J Psychiatry; 2009 Oct 15; 166(10):1118-23. PubMed ID: 19723786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.